Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 41

Trial Status

Completed1
Recruiting2

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT01818661Phase 4Recruiting
Longitudinal Multi-Modality Imaging in Progressive Apraxia of Speech
Apraxia of SpeechNon-fluent AphasiaPPA+2 more
PrincipalinvestigatorStart date: 2018-07-01
NCT01723553Phase 1Completed
Amyloid-related Imaging Abnormalities (Microbleeds) in Atypical AD
Atypical Alzheimers DiseaseLogopenic Variant of Primary Progressive Aphasia (LPA)Posterior Cortical Atrophy (PCA)
Principalinvestigator
NCT02605785Not ApplicableRecruiting
A Molecular Anatomic Imaging Analysis of Tau in Progressive Supranuclear Palsy
Progressive Supranuclear Palsy
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Kyrana Tsapkini, PhD

Johns Hopkins University

Related
8 trials

Shared therapeutic areas:

Aphasia, Primary ProgressiveAtypical Alzheimer's DiseasePPA

Worked with same sponsors:

National Institute on Deafness and Other Communication Disorders (NIDCD)
Similarity Score10%

Maya L Henry, PhD

University of Texas at Austin

Related
4 trials

Shared therapeutic areas:

Aphasia, Primary ProgressivePrimary Progressive Nonfluent AphasiaLogopenic Variant of Primary Progressive Aphasia (LPA)

Worked with same sponsors:

National Institute on Deafness and Other Communication Disorders (NIDCD)
Similarity Score10%

Eloi Magnin, MD

Centre Hospitalier Universitaire de Besancon

Related
1 trials

Shared therapeutic areas:

Supranuclear Palsy, Progressive
Similarity Score3%

emilie garrido pradalie

APHM

Related
35 trials

Shared therapeutic areas:

Supranuclear Palsy, Progressive
Similarity Score3%

François Sellal, MD

Hôpitaux Civils (Hopital Louis Pasteur) de Colmar

Related
1 trials

Shared therapeutic areas:

Supranuclear Palsy, Progressive
Similarity Score3%

Florence Pasquier, MD

Centre Hospitalier Régional, Universitaire de Lille

Related
1 trials

Shared therapeutic areas:

Supranuclear Palsy, Progressive
Similarity Score3%

Frisoni Giovanni, MD

University Hospital, Geneva

Related
1 trials

Shared therapeutic areas:

Supranuclear Palsy, Progressive
Similarity Score3%

Prabesh Kanel, PhD

University of Michigan

Related
4 trials

Shared therapeutic areas:

Supranuclear Palsy, Progressive
Similarity Score3%

Jean-Christophe Bier, MD

Hopital ERASME, Brussels

Related
1 trials

Shared therapeutic areas:

Supranuclear Palsy, Progressive
Similarity Score3%

Jean-François Démonet, MD

Centre hospitalier universitaire vaudois, Lausanne

Related
1 trials

Shared therapeutic areas:

Supranuclear Palsy, Progressive
Similarity Score3%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT01818661Phase 4PrincipalInvestigator

Longitudinal Multi-Modality Imaging in Progressive Apraxia of Speech

Apraxia of SpeechNon-fluent AphasiaPPA+2 more
Recruiting
NCT01723553Phase 1PrincipalInvestigator

Amyloid-related Imaging Abnormalities (Microbleeds) in Atypical AD

Atypical Alzheimers DiseaseLogopenic Variant of Primary Progressive Aphasia (LPA)Posterior Cortical Atrophy (PCA)
Completed
NCT02605785Not ApplicablePrincipalInvestigator

A Molecular Anatomic Imaging Analysis of Tau in Progressive Supranuclear Palsy

Progressive Supranuclear Palsy
Recruiting

All 3 trials loaded